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Abstract
Mercury is a potent toxicant of concern to both the general public and occupationally exposed
workers (e.g., dentists). Recent studies suggest that several genes mediating the toxicokinetics of
mercury are polymorphic in humans and may influence inter-individual variability in mercury
accumulation. This work hypothesizes that polymorphisms in key glutathione synthesizing
enzyme, glutathione s-transferase, and selenoprotein genes underlie inter-individual differences in
mercury body burden as assessed by analytical mercury measurement in urine and hair,
biomarkers of elemental mercury and methylmercury, respectively. Urine and hair samples were
collected from a population of dental professionals (n=515), and total mercury content was
measured. Average urine (1.06±1.24 ug/L) and hair mercury levels (0.49±0.63 ug/g) were similar
to national U.S. population averages. Taqman assays were used to genotype DNA from buccal
swab samples at 15 polymorphic sites in genes implicated in mercury metabolism. Linear
regression modeling assessed the ability of polymorphisms to modify the relationship between
mercury biomarker levels and exposure sources (e.g., amalgams, fish consumption). Five
polymorphisms were significantly associated with urine mercury levels (GSTT1 deletion), hair
mercury levels (GSTP1-105, GSTP1-114, GSS 5’), or both (SEPP1 3’UTR). Overall, this study
suggests that polymorphisms in selenoproteins and glutathione-related genes may influence
elimination of mercury in the urine and hair or mercury retention following exposures to elemental
mercury (via dental amalgams) and methylmercury (via fish consumption).
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INTRODUCTION1
Mercury toxicokinetics and toxicodynamics are largely influenced by the chemical form of
the metal. Though humans are exposed to mercury through a variety of sources (e.g.
vaccines, thermostats, compact fluorescent lights), the main sources of elemental mercury
(inorganic) and methylmercury (organic) exposure come from dental amalgams and fish
consumption, respectively (ATSDR, 1999; Clarkson and Magos, 2006). Urine is commonly
used to measure elemental mercury exposure and blood or hair to measure methylmercury
exposure (Berglund et al., 2005; Clarkson et al., 2007). However, each biomarker shows
tremendous inter-individual variation, and this complicates risk assessment. For example,
mercury typically accumulates 250 times more in the hair than it does in the blood, though
this ratio ranges widely among individuals (ATSDR, 1999; Berglund et al., 2005). The half-
life of methylmercury in hair ranges from 33 to 120 days (Birke et al., 1972), and the half-
life of inhaled elemental mercury ranges from 35-90 days in the whole body (Hursh et al.,
1976). Failure to understand such inter-individual variation in the accumulation of mercury,
its distribution to various biomarkers and its half-life in the body may lead to risk
assessment decisions that fail to protect the most susceptible individuals.
Inter-individual variation in mercury biomarkers may be partly explained by genetic factors.
For example, mercury is eliminated following conjugation with glutathione, a process that
may involve glutathione s-transferases (GSTs; GST theta 1, GSTT1; GST mu 1, GSTM1;
GST pi 1, GSTP1) and indirectly depends on enzymes of the glutathione synthesis and
degradation pathways (glutamate-cysteine ligase catalytic and modifier submits, GCLC,
GCLM; glutathione synthetase, GSS; glutathione reductase, GSR; γ-glutamyltransferase 1,
GGT1) (Ballatori and Clarkson, 1985; Rooney 2007). Selenoproteins (e.g. selenoprotein pi
1, SEPP1; glutathione peroxidases, GPX) combat the oxidative stress created by mercury
and bind the toxicant directly via selenocysteine residues (Chen et al., 2006). Genetic
polymorphisms are ubiquitous among these glutathione and selenoprotein genes that
facilitate the distribution, metabolism and elimination of mercury. As documented in recent
epidemiological studies, such polymorphisms can influence mercury biomarker levels,
which may ultimately improve understanding of inter-individual variability following
exposure to methylmercury (Custodio et al., 2004; Engström et al., 2008; Gundacker et al.,
2007, 2009) and elemental mercury (Custodio et al. 2005; Gundacker et al., 2009).
The aforementioned studies provide early evidence that genetic polymorphisms in key
mercury handling genes may underlie differences in mercury distribution and accumulation
in exposure biomarkers. However, discrepancies exist among the studies (see Table 1 for
more details, including results of this study). For example, Custodio et al. (2004) found the
minor allele (T) of the GSTP1-114 polymorphism (rs1138272) to be associated with
increased blood mercury levels while Engström et al. (2008) found the opposite in subjects
with higher fish consumption. Disparate findings may be related to differences between the
studies in terms of biomarkers examined, statistical methodologies utilized, sources of
mercury exposure, and polymorphism frequency. Here we aim to address these limitations
1Abbreviations: CRM (certified reference material); GST (glutathione s-transferase); Hg (mercury); MAF (minor allele frequency);
MDA (Michigan Dental Association); NHANES (National Health and Nutrition Examination Survey); ln (natural log); SNP (single
nucleotide polymorphism); UTR (untranslated region)
Goodrich et al. Page 2
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2012 December 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
and help improve understanding of gene-environment interactions influencing mercury
biomarker levels by studying both forms of mercury (through analytical measurement of
biomarkers in urine and hair), various sources of exposure (dental amalgams and fish as
determined from surveys), and additional polymorphisms in glutathione-related (GSTT1,
GSTM1, GSTP1, GSTM3, GGT1, GSS, GSR, GCLC, GCLM) and selenoprotein (SEPP1,
GPX1, GPX4) genes in a group of dental professionals that are exposed to mercury via
occupational and environmental routes. Polymorphisms in the listed genes, which are
important in the metabolism and elimination of mercury, are hypothesized to affect
individual susceptibility to elemental mercury and/or methylmercury accumulation in the
body as assessed by urine and hair biomarkers.
MATERIALS AND METHODS
Study Population
A convenience sample of 515 dental professionals (dentists, hygienists, and other related
professions) was recruited during the 2009 (n=231) and 2010 (n=284) Michigan Dental
Association (MDA) Annual Conventions. Institutional Review Board (IRB) approval was
obtained for this study from the University of Michigan (HUM00027621).
Survey Data
For each participant a self-administered survey provided information on subject
demographics (e.g., age, gender, weight), occupational practices (e.g., hours worked per
week, number of amalgams removed and placed per week), and personal exposures to
elemental mercury (amalgams in subject’s mouth) and methylmercury (fish consumption).
Subjects provided detailed information on fish consumption (e.g., portion size, type of fish,
monthly consumption). Fish data were used to estimate a mercury intake variable (ug per kg
body weight per day) using mercury concentration data from the U.S. Food and Drug
Administration for each fish species (Bahnick et al., 1994; Mierzykowski et al., 2001; U.S.
FDA).
Mercury Exposure Assessment
Spot urine samples, biomarkers of elemental mercury exposure, (>30 mL) were collected
from each participant and stored frozen. Hair samples, biomarkers for methylmercury, (>10
mg) were cut from the occipital region of the scalp, and the first 2 cm of hair (proximal end)
were used for measurement. Total mercury levels in urine and hair were measured using a
direct mercury analyzer (DMA-80, Milestone Inc., CT) according to U.S. EPA Method 7473
as previously described (Basu et al., 2010; Paruchuri et al., 2010). Quality control measures
included incorporating one blank, one replicate sample, and a certified reference material
(CRM; hair: NIES Japan CRM#13; two urine CRMs: QMEQAS08U-01 and ClinChek;
dogfish liver: DOLT, National Research Council Canada) in every batch of 10-15 samples.
All samples exceeded the theoretical method detection limits, defined as 3x SD of blanks,
(0.03 ug/L mercury for urine and 0.01 ug/g mercury for hair). Mean (±SD) recovery of
mercury from CRMs was 94.4 ± 15.4%. Mean within day (3.1 ± 1.7%) and between day
(6.7 ± 6.8%) variability of CRMs were similar to that of duplicated subject samples.
Genotype Analyses
To obtain DNA from buccal cells, subjects swabbed the inside of their cheeks with four
cotton swabs for fifteen seconds each. Cotton swabs were stored at room temperature in 0.5
mL of buffer (100 mM sodium chloride, 10 mM Tris base, 10 mM EDTA, 0.5% sodium
dodecyl sulfate with 0.1 mg/mL of Proteinase K, according to Min et al., 2006). DNA was
purified from buccal cells using Promega SV Wizard Genomic DNA purification kits
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(Promega Corporation, Madison, WI), and DNA quantification was performed using
PicoGreen reagent with relative fluorescence measured by a Perkin Elmer HTS 7000 Plus
Bioassay Reader (Shelton, CT).
Over the two study years, fifteen polymorphisms were genotyped in glutathione s-
transferases, glutathione synthesizing enzymes, and selenoproteins, but in a given study year
ten or eleven polymorphisms were genotyped. Fourteen polymorphisms (rs1695, rs1138272,
rs3877899, rs713041, rs7579, rs17883901, rs41303970, rs1050450, rs5751901, rs7483,
rs3761144, rs1002149, rs2911678, GSTT1 deletion) were genotyped using Taqman Allelic
Discrimination Assays (Applied Biosystems; Livak et al., 1995). Results were read and
interpreted using an ABI 7700 (Carlsbad, CA). All primers and probes were pre-designed by
Applied Biosystems except for the GSTT1 deletion genotyping which utilized primers and
probes designed by Mordukhovich et al. (2009). The GSTM1 deletion polymorphism was
genotyped in the 2009 samples using the PCR-based method of Lee et al. (2009). GSTT1
and GSTM1 genotyping resulted in two distinct groups: deletion homozygotes and
individuals with at least one intact copy of the gene.
Statistical Analysis
All statistical analyses were performed using PASW Statistics v18 (Chicago, IL). The 2009
and 2010 data were grouped together given that demographics, mercury biomarker levels
and exposures had similar distributions both years. In all analyses, mercury values were
natural log-transformed to achieve normality. The influence of genetic polymorphisms,
assuming additivity of variant alleles, on mercury biomarker levels (hair or urine) was
studied via simple linear regression models with one ordinal variable per polymorphism
(coded 1=major homozygote, 2=heterozygote, 3=minor homozygote) in each model. The
association of genetics with urine mercury and hair mercury biomarkers adjusted for
predictors was also assessed by multiple linear regression. Base models without genetic
variables were first created. All variables (e.g., demographics, fish consumption,
occupational exposures) were included in the base model, and insignificant variables
(p>0.05) were removed via a manual backward selection process. Final base models
consisted of significant predictors of hair or urine mercury (p<0.05 for parameter estimate)
unless otherwise noted. The effect of genotype (main effect and interaction with each
exposure predictor variable) was then assessed with separate models for each
polymorphism. Models with separate dummy variables for heterozygotes and minor
homozygotes and interaction terms for each were also run (data not shown). The effect
estimates (magnitude, direction, significance) for genotype obtained from this method,
which did not assume genetic additivity, were similar to results reported here.
According to the method of Levine and Fahy (1945), which has been shown to reduce
variability of metal excretion associated with spot urine samples, urine mercury levels were
adjusted for the mean specific gravity (1.017) of the study population (Mason and Calder,
1994). The linear regression models described were run with unadjusted and adjusted urine.
Parameter estimates did not notably change and significance only changed in a few instances
in specific gravity adjusted models. Unadjusted models are reported here unless otherwise
noted. In all urine mercury models, eight subjects were excluded due to a history of kidney
disease (lithiasis, pyelonephritis, and/or orthostatic proteinuria) that may have influenced
urinary excretion of mercury.
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RESULTS
Descriptive Statistics
The majority of the 515 participants provided urine (n=502) and hair (n=505). Subjects
lacking both biomarker samples and demographic information were excluded (n=4). Sixty-
one percent of all subjects were female, and the majority of the population (>90%) self-
identified racially as Caucasian. Table 2 provides average (±SD) demographic and
occupational variables for the total population and occupation-stratified population (dentists,
n=243 vs. non-dentists, n=268). Genders were unequally distributed in the occupational
groups as 24% of dentists were female compared to 95% of non-dentists (e.g., dental
hygienists, dental assistants). Stratification of subjects into two occupational groups yielded
significant differences (p<0.05) between the groups. On average, dentists were older,
removed and placed more dental amalgams in the office, and had more amalgams in their
own mouths compared with non-dentists.
Mercury Biomarkers
Average mercury biomarker levels are reported in Table 2. Urine mercury (mean ±SD,
1.04±1.18 ug/L; median 0.66 ug/L) ranged from 0.03 to 9.26 ug/L with a distribution
resembling that of the U.S. population according to the National Health and Nutrition
Examination Survey (NHANES 2003-2004, median 0.48 ug/L; CDC, 2009). Dentists had
significantly higher urine mercury levels compared to non-dentists (1.37±1.3 ug/L vs.
0.75±0.97 ug/L; p<0.001 for ANOVA comparing natural log-transformed values). The
distribution of hair mercury (0.49±0.63 ug/g; range 0.02 to 6.15 ug/g) also resembled
NHANES data from 1999-2000 (mean 0.47 ug/g; McDowell et al., 2004). Dentists had
significantly higher hair mercury levels compared to non-dentists (0.69±0.81 vs. 0.31±0.33
ug/g; p<0.001) even though the estimated mercury intake from fish consumption was not
significantly different between the two groups.
Genotype and Mercury Biomarkers
All genotyped polymorphisms achieved Hardy-Weinburg Equilibrium. Minor allele
frequencies (MAF) for each polymorphism were generally similar to HapMap reference
Caucasian population MAFs (Table 3). In statistical models comparing mercury levels
among genotype groups, all polymorphisms were divided into major homozygote,
heterozygote, and minor homozygote groups with the exception of GSTM1 and GSTT1
deletion polymorphisms which were divided into two genotype groups (double deletion vs.
at least one intact copy).
Simple linear regression models were used to test the differences in mean natural log-
transformed urine (ug/L) or hair (ug/g) mercury levels among genotype groups for each
polymorphism. Three statistically significant findings emerged (β estimate (95% CI)
reported in Table 3). Urine levels were lower among individuals with double deletion of
GSTT1 compared to those with the intact gene (-0.27 (95% CI: -0.52, -0.02) ug/L change in
ln(urine Hg) with GSTT1 deletion). Likewise, individuals with the T allele for SEPP1
3’UTR (rs7579) had lower urine mercury levels (-0.16 (95% CI: -0.3, -0.02) ug/L change in
ln(urine Hg) with each T alelle). Hair mercury levels differed by GSTP1-105 (rs1695)
genotype with minor homozygotes (GG) exhibiting the lowest hair mercury measurements
(-0.22 (-0.36, -0.07) ug/g change in ln(hair Hg) with each G allele).
Linear Regression Modeling of Urine Biomarker
Linear regression was used to model natural log-transformed urine mercury levels with
significant exposure variables. In the final base model, significant predictors were number of
dental amalgams in the subjects’ mouth (‘amalgam’), amalgams removed or placed per
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week in the dental office (‘amalgam handled’, an ordinal variable), and occupation (dentist
vs. non-dentist) (Table 4). The categories for ‘amalgam handled’ were defined as follows:
reference (0 amalgams handled), low (1 to 20 per week), medium (21 to 45), and high (>45).
The effect of genotype for each polymorphism was tested (main effect, interactions between
genotype and the three exposure variables). For all models, only the interactions between
genotype and ‘amalgam’ are reported here as amalgams were the dominant predictor of
urine Hg levels. The number of subjects in each model ranged from 204 to 466 depending
on the polymorphism; not all polymorphisms were genotyped both years, and some subjects
did not provide adequate DNA to complete the genotyping.
Urine mercury models with nominally significant (p<0.05) genotype (main effect or
interaction) terms are reported in Table 4 (see Supplemental Table 1 for all urine models).
Significant main effects of genotype were observed for SEPP1 3’UTR (β estimate (95%
CI)=-0.26 (-0.43, -0.08) ug/L) and GSTT1 deletion (-0.25 (-0.5, -0.00) ug/L), though the
latter was only observed when urine was first adjusted for specific gravity. A significant
interaction was observed with SEPP1 3’UTR T alleles and personal amalgams (β (95%
CI)=0.04 (0.01, 0.07) ug/L), though the interactions with amalgam handled and occupation
were not significant (data not shown).
Linear Regression Modeling of Hair Biomarker
Hair mercury levels (ln-transformed) were modeled using statistical methods similar to urine
mercury modeling. The final base model included the most significant predictor of hair Hg,
‘fish Hg’ (calculated ug Hg intake per kg body weight per day from fish consumption, β
(95% CI)=3.62 (2.96, 4.28) ug/g, see Table 5). Addition of genotype into the model resulted
in two genotypes with significant main effects (GSTP1-105, rs1695, β (95% CI)= -0.22
(-0.38, -0.06) ug/g; GSTP1-114, rs1138272, -0.31 (-0.6, -0.03) ug/g). Significant interactions
between genotype and fish Hg were also observed in models with SEPP1 3’UTR and GSS 5’
(rs3761144). Individuals with the minor allele (T) of SEPP1 3’UTR accumulated less
mercury in the hair per intake from fish consumption (β (95% CI)=-1.61(-2.82, -0.4) ug/g
change in ln(hair Hg) with each T allele). The opposite relationship was observed with the
minor allele of GSS 5’ (G) and fish Hg (1.88 (0.44, 3.31) ug/g change in ln(hair Hg) per G
allele). To highlight the nature of these results, two scatterplots of hair mercury by mercury
intake from fish (both ln-transformed) are shown stratified by SEPP1 3’UTR genotype
(Figure 1a) and GSS 5’ genotype (Figure 1b). Significant results (main effect or genotype-
by-exposure variable interactions) were not observed for any other polymorphism in the
models of urine or hair mercury (see Supplemental Tables 1 and 2 for all urine and hair
models).
DISCUSSION
Recent epidemiological studies suggest that seven genetic polymorphisms in GSTs and
glutathione synthesizing enzymes may influence mercury accumulation in common
biomarkers (hair, blood, urine) following exposure to elemental mercury or methylmercury
(Custodio et al., 2004, 2005; Engström et al., 2008; Gundacker et al., 2007, 2009). Here, we
build upon these studies and assess the influence of fifteen polymorphisms in GSTs,
glutathione synthesizing enzymes and selenoproteins on the accumulation of both elemental
mercury and methylmercury in urine and hair biomarkers, respectively, in a population of
occupationally and environmentally exposed dental professionals. Our results suggest that
five polymorphisms may affect accumulation of mercury in urine (GSTT1 deletion), hair
(GSTP1-105, GSTP1-114, GSS 5’) or both (SEPP1 3’UTR).
Four nominally significant (p<0.05) polymorphism-mercury biomarker relationships were
observed that have not been reported previously, including two SNPs (GSS 5’, SEPP1
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3’UTR) genotyped for the first time in a mercury-gene study. A deletion polymorphism in
GSTT1 was associated with decreased urine mercury in both simple (Table 3) and
multivariate linear regression (Table 4), though the latter was significant only after adjusting
for specific gravity. Effect modification of SEPP1 3’UTR genotype on the relationship
between exposure source and mercury biomarker was observed in both urine and hair
mercury models. The minor allele, T, of the SEPP1 3’UTR SNP was linked to lower urine
mercury levels on average (Table 3). However, upon adjusting for elemental mercury
exposures, each T allele was associated with greater urine mercury accumulation per
amalgam (Table 4). In hair mercury models, SEPP1 3’UTR T was associated with lower
hair mercury per unit of intake from fish consumption (Figure 1a, Table 5). Contrariwise,
the GSS 5’ minor allele was associated with increasing hair mercury concentration per unit
of fish mercury (Figure 1b, Table 5). This study also reports associations between minor
alleles of two SNPs, GSTP1-105 and GSTP1-114, and decreased hair mercury
concentrations though significant effect modification on the relationship between mercury
intake from fish consumption and hair levels were not observed. Previous gene-mercury
biomarker studies have assessed the same GSTP1 SNPs with conflicting results (Custodio et
al., 2004; Engström et al., 2008; Gundacker et al., 2009).
Dental professionals provide a convenient sample to assess mercury-gene interactions as
they share common exposure routes with the general population (e.g. fish consumption,
personal amalgams) along with an additional occupational exposure. While dentists’
occupational exposures are typically higher than the average population, a shift towards use
of composite resin fillings and safer handling of mercury may result in dentists having urine
biomarker levels comparable to that of the general U.S. population (Eklund et al., 2010).
Here, participating dentists and other related professionals (e.g., dental hygienists, dental
assistants) exhibited urine and hair mercury levels similar to that of the general U.S.
population according to NHANES (CDC, 2009; McDowell et al., 2004). The best predictors
of urine mercury levels were personal dental amalgams and occupational exposure to
amalgams with dentists having the greatest exposure and biomarker levels. Study subjects
displayed a wide range of methylmercury exposure from fish consumption, enabling the
study of both mercury forms.
Immense variability in mercury biomarker measurements and half-lives has been observed
in human populations, complicating risk assessment of both elemental and methylmercury
(Berglund et al., 2005; Burke et al., 1972; Hursh et al., 1976). Differential metabolism of
mercury in the body could affect its half-life and reactivity, as conjugated mercury is less
able to induce oxidative stress, bind to thiol groups, and/or inhibit proteins in the body.
Functional GSTs, adequate glutathione and selenoproteins are essential for protection
against mercury (Ballatori and Clarkson, 1985; Chen et al., 2006; Clarkson and Magos,
2006). Polymorphisms are ubiquitous among the genes encoding these mercury-handling
proteins and have the potential to modify mercury toxicokinetics, reflected partially in
biomarker levels, via altered enzyme activity or gene expression.
Previous studies assessing the association of genetic polymorphisms with mercury
biomarkers focused on seven variants in glutathione synthesizing enzymes and glutathione
s-transferases, six of which were genotyped here (see Table 1). Our results follow several
trends previously reported, and this study further explores genotype-mercury relationships
that were inconsistent in past research. Custodio et al. (2005) found the T allele of GCLM
rs41303970 to be associated with increased blood, plasma and urine mercury in gold miners
occupationally exposed to elemental mercury. Our study did not find associations between
urine mercury levels and GCLM genotype. Genotype associations may differ based on the
level of exposure as the miners had almost seven-fold higher urinary mercury compared to
the dental population (miners: median=4.5 ug/L, maximum=230 ug/L; dental population:
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median=0.7 ug/L, maximum=9.3 ug/L). Other studies have explored the influence of
glutathione-related polymorphisms on urine mercury levels, and a lack of significant
outcomes indicate that the polymorphisms studied to date may not influence the variability
observed in urinary excretion of elemental mercury. Alternatively, given that the impact of
any individual polymorphism on mercury accumulation is expected to be small, studies to
date may have insufficient power to detect some associations.
Two previous epidemiological studies have assessed the relationship between glutathione-
related polymorphisms and hair mercury levels (Gundacker et al., 2007, 2009), and four
explored the modifying effect of polymorphisms on methylmercury accumulation from fish
consumption using blood as an exposure biomarker (Custodio et al., 2004; Gundacker et al.
2007, 2009; Engström et al., 2008). Several associative findings linking polymorphisms to
hair or blood biomarker levels were inconsistent among studies (Table 1). Gundacker et al.
found GSTM1 and GSTT1 deletions together (2007) or in combination with other SNPs
(2009) to associate with higher hair mercury levels. The present study did not observe
significant associations between GSTM1 or GSTT1 deletion polymorphisms and hair
mercury concentrations when modeling single polymorphisms or combined GSTT1/GSTM1
genotype (both genes intact vs. at least one deletion).
Conflicting relationships between two GSTP1 SNPs (105 A>G; 114 C>T) and hair or blood
biomarkers were observed among past studies. Given that both SNPs encode amino acid
changes in GSTP1 that decrease enzyme activity (Ali-Osman et al., 1997), these SNPs may
alter the ability of GSTP1 to conjugate glutathione to mercury or transport mercury-
glutathione conjugates. This study suggests that both the GSTP1-105 G and GSTP1-114 T
alleles are linked to decreased hair mercury levels (Table 5). Engström et al. (2008) found
that carriers of GSTP1-105 G and/or GSTP1-114 T accumulated less mercury in
erythrocytes per measured polyunsaturated fatty acids (an indicator of fish consumption),
suggesting a similar trend as the findings of this study for GSTP1 variant alleles. In contrast,
other studies found associations between GSTP1-105 G or GSTP1-114 T and higher hair or
blood biomarker measurements, after adjustment for fish consumption in many cases and
often in combination with other polymorphisms (Custodio et al., 2004; Gundacker et al.,
2009). Several factors may influence these incongruent results. While hair and blood,
especially erythrocytes, are both biomarkers for methylmercury exposure, two centimeters
of scalp hair represent the average exposure over two months with a lag period of
approximately one month while blood mercury levels reach a steady-state among consistent
fish consumers but fluctuate among infrequent consumers (Berglund et al., 2005). Thus,
while similar gene-mercury relationships could be observed in models of hair and blood
mercury, they may be influenced by the frequency, duration, and dose of the exposure.
Several significant findings in previous studies for GSTP1-105 and GSTP1-114 involved
polymorphism combinations. Our sample size was not large enough to confidently test
combinations of all fifteen polymorphisms studied.
Genotype of the SEPP1 3’UTR SNP significantly impacted both urine Hg (positive
interaction with amalgam) and hair Hg (negative interaction with fish mercury) models. This
SNP is found in the 3’ untranslated region (UTR), a gene region crucial to the regulation of
selenocysteine incorporation. Selenocysteine is an amino acid unique to selenoproteins that
can bind mercury-selenium conjugates or methylmercury (Khan and Wang, 2009). SEPP1
expression depends on genotype and selenium availability and can also be influenced by
gender and BMI (Méplan et al., 2007, 2009). The 3’UTR T allele is linked to greater SEPP1
expression among people supplemented with selenium and higher prevalence of the 60 kDa
isoform of SEPP1 which has more selenocysteine residues and greater mercury binding
capacity (Méplan et al., 2007, 2009). Elevated elemental mercury exposure increases SEPP1
expression and the ability of SEPP1 to bind mercury as evident in highly exposed miners
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(Chen et al., 2006). In the dental population, individuals with CT or TT genotype had lower
urine mercury levels on average (Table 3). However, the T allele modified the relationship
between the source of exposure, dental amalgams, and urine mercury levels. At higher
exposure levels, CT/TT individuals excrete more mercury in the urine per amalgam
compared to those with the CC genotype (Table 4). The opposite relationship is observed for
the hair biomarker whereby each additional T allele is associated with less accumulation of
mercury in the hair given methylmercury intake from fish (Figure 1a). Expression changes
of SEPP1 linked to the T genotype may explain the complex relationship observed between
SEPP1 genotype, mercury biomarker levels, and exposures to mercury that may be
complicated further by micronutrient status (e.g. selenium) and chemical speciation of
mercury. Higher expression of SEPP1 from the CT or TT genotypes could affect mercury
binding and subsequent distribution to various tissues. Excretion of elemental mercury and
methylmercury via urine and hair, respectively, may be differentially modified by this SNP
which warrants further investigation and incorporation of selenium biomarker levels into
multivariate analysis.
Glutathione synthetase (GSS) is involved in glutathione synthesis, and a SNP upstream of
the coding region (5’ C>G) may modify the relationship between mercury intake from fish
consumption and hair mercury levels. With each variant allele (G), more mercury is
accumulated in the hair given intake from fish consumption (Figure 1b, Table 5). This SNP,
which is associated with sporadic amyotrophic lateral sclerosis among individuals with past
heavy metal exposure, may influence expression of GSS directly or may be a marker for an
expression-altering SNP (Morahan et al., 2007). Decreased expression of GSS leading to
decreased glutathione synthesis could impact the body’s ability to eliminate methylmercury
as a glutathione conjugate with the higher body burden reflected in hair Hg levels.
We found several nominally significant associations between polymorphisms in glutathione-
related enzymes and SEPP1 and elemental mercury or methylmercury biomarker levels in a
population of dental professionals despite several study limitations. This cross-sectional
study was dependent upon self-reporting of mercury exposures (fish consumption, number
of amalgams handled). Though the voluntary nature of subject participation could lead to
selection bias, our subjects did not know their mercury levels or genotype prior to
participation in the study, and we obtained a range of mercury biomarker levels similar to
that of the general U.S. population (CDC, 2009; McDowell et al., 2004).
In the dually exposed MDA cohort, total Hg in urine was predicted by amalgam exposures
and occupation, and hair Hg levels correlated with estimated mercury intake from fish. As
such, total Hg in urine and hair were assumed to reflect elemental mercury and
methylmercury exposures, respectively. While urine and hair are often used as biomarkers
of different mercury species (Berglund et al., 2005), cohorts occupationally exposed to
elemental mercury attribute a fraction of hair Hg to the elemental mercury exposure source
(Wranová et al., 2008). Likewise, in populations with negligible elemental mercury
exposure, urine Hg concentrations correlate with fish consumption (Ohno et al., 2007).
While the possibility of such biomarker crossover cannot be eliminated, urine and hair Hg
concentrations in the MDA cohort primarily reflect elemental mercury and methylmercury
exposures, respectively.
In genotype analyses, the sample size was decreased due to inadequate DNA from a subset
of subjects, and not all polymorphisms were genotyped each collection year resulting in
sample sizes as small as 204 in some models. Previous gene-mercury biomarker studies
found significant impacts of dual polymorphism combinations on mercury biomarker levels.
However, due to the sample size and number of loci genotyped, polymorphism
combinations could not be tested confidently in this study without encountering errors of
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multiple testing or insufficient power due to small numbers of cases with some genotype
combinations. Without studying polymorphism combinations, we may have missed several
significant relationships with mercury biomarkers that would mirror findings in previous
studies. Overall, while several significant genotype-mercury biomarker relationships were
observed (p<0.05), none remain significant after correction for multiple testing (p<0.002).
As such, the nominally significant results reported in the MDA cohort should be considered
trends and require further exploration in future cohort studies with greater power.
In conclusion, this study adds to growing knowledge about genetic associations with
mercury biomarker levels and inter-individual variability in the toxicokinetics of elemental
mercury and methylmercury. Results suggest that five polymorphisms in GSTP1, GSTT1,
GSS and SEPP1 may influence urine and hair mercury levels, though further investigation is
warranted. Future research on genetic factors influencing mercury toxicokinetics should
assess both major mercury exposure sources (amalgam, fish consumption) in larger cohorts
using all three biomarkers (urine, blood, hair) and more polymorphisms in glutathione
related enzymes, selenoproteins, and proteins involved in mercury transport to help ascertain
sources of biomarker variability and to narrow the gap between the perceived and true health
risks accompanying mercury exposure.
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Highlights
➢ We explore the influence of 15 polymorphisms on urine and hair Hg levels.
➢ Urine and hair Hg levels in dental professionals were similar to the US
population.
➢ GSTT1 and SEPP1 polymorphisms associated with urine Hg levels.
➢ Accumulation of Hg in hair following exposure from fish was modified by
genotype.
➢ GSTP1, GSS, and SEPP1 polymorphisms influenced Hg accumulation in
hair.
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Figure 1.
Modification of the relationship between Hg intake from fish consumption and hair Hg
levels by a) SEPP1 3’UTR (C>T) genotype and b) GSS 5’ (C>G) genotype. Note: hair Hg
and Hg intake are natural log-transformed, though axes are labeled with untransformed units
for ease of interpretation.
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Table 2
Mean (SD) of key demographic and exposure variables in total population and occupation stratified
populations.
Total Population Occupation Stratified
Dentists Non-Dentists
n 511 243 268
% Female 61.3 24.3 94.8
BMI (kg/m2) 26.4 (4.7) 26.4 (4.0) 26.5 (5.3)
Age (years) 52.1 (12.1) 56.1 (11.6) 48.3 (11.2)b
Hours worked/ week (in past 6 months) 27.9 (11.6) 29.1 (11.1) 27.0 (11.9)a
# Amalgam (personal) 4.1 (4.1) 4.6 (4.2) 3.7 (3.9)a
# Amalgam placed/ week 12.1 (25.8) 20.4 (31.1) 4.7 (16.7)b
# Amalgam removed/ week 13.3 (23.1) 23.2 (27.2) 4.4 (13.4)b
Hg Intake (ug/kg body weight/day) 0.08 (0.13) 0.09 (0.14) 0.08 (0.12)
Urine Hg (ug/L) 1.04 (1.18) 1.37 (1.3) 0.75 (0.97)b
Hair Hg (ug/g) 0.49 (0.63) 0.69 (0.81) 0.31 (0.33)b
a,b
denote p-value <0.05 and <0.001, respectively, for ANOVA test comparing dentists and non-dentists. ANOVA comparing urine and hair Hg
used natural log-transformed values.
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